The Respiratory Syncytial Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics.
- Assay Description:
- 1 hour incubation (37°C) + 30 min. (20~25°C) + 15 min. (20~25°C) = 1 hour, 45 min. total incubation time
- Catalog number:
- IB79887
- configuration:
- 96 Determinations, 12x8 removable strips
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- 510(k) Exempt - IVD
- MSDS:
- Please inquire
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Protocol:
- Sample types:
- Serum and Plasma (citrate, heparin)
- Sample volume:
- 100 µL of properly diluted (1:100) unknown / determination
- standards:
- Cut-off controls, ready to use
- storage:
- 2 - 8 °C
- sensitivity:
- Please see protocol for assay-specific performance characteristics
- Species:
- Human
